Prednisolone Sodium Phosphate Compounded Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Change to read:
Prednisolone Sodium Phosphate Compounded Oral Solution contains NLT 90.0% and NMT 110.0% of the labeled amount of prednisolone (C21H28O5).
Prepare Prednisolone Sodium Phosphate Compounded Oral Solution containing (USP 1-May-2022) 10 mg/mL of prednisolone (USP 1-May-2022) as follows (see Pharmaceutical Compounding—Nonsterile Preparations 〈795〉).
| Prednisolone (as prednisolone sodium phosphate) (USP 1-May-2022) powder | 1 g (1.34 g of prednisolone sodium phosphate) |
| Purified Water | A small amount |
| Vehicle: a 1:1 mixture of Cherry Syrupa and Ora-Sweet,b a sufficient quantity to make | 100 mL |
a Humco, Texarkana, TX.
b Perrigo Pharmaceuticals, Allegan, MI.
Pour the weighed prednisolone sodium phosphate powder into a suitable container. Wet the powder with a small amount of Purified Water, and triturate to make a smooth paste. Add the Vehicle to make the contents pourable. Transfer the contents, stepwise and quantitatively, to a calibrated container. Add sufficient Vehicle to bring to final volume. Shake to mix well.
2 ASSAY
Change to read:
2.1 Procedure
Solution A: Dissolve 2.0 g of 1-pentanesulfonic acid sodium in 1000 mL of water.
Solution B: Mix 980 mL of Solution A with 20 mL of tetrahydrofuran. Adjust with phosphoric acid to a pH of 2.0.
Mobile phase: Methanol and Solution B (45:55)
Standard solution: 0.54 (USP 1-May-2022) mg/mL of prednisolone sodium phosphate, (USP 1-May-2022) prepared from USP Prednisolone Sodium Phosphate RS in Solution B
Sample solution: Shake each bottle of Oral Solution thoroughly. Transfer 1.0 mL of Oral Solution to a 25-mL volumetric flask, dilute with Solution B to volume, and mix well.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 246 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Flow rate: 1.0 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
[Note—The retention time for prednisolone is about 11.3 min.]
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0% for replicate injections
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of prednisolone (C21H28O5) in the portion of Oral Solution taken:
Result = (rU/rS) × (CS/CU) × (Mr1/Mr2) (USP 1-May-2022) × 100
rU = peak response of prednisolone sodium phosphate (USP 1-May-2022) from the Sample solution
rS = peak response of prednisolone sodium phosphate (USP 1-May-2022) from the Standard solution
CS = concentration of USP Prednisolone Sodium Phosphate RS (USP 1-May-2022) in the Standard solution (mg/mL)
CU = nominal concentration of prednisolone in the Sample solution (mg/mL)
Mr1 = molecular weight of prednisolone, 360.44
Mr2 = molecular weight of prednisolone sodium phosphate, 484.39 (USP 1-May-2022)
Acceptance criteria: 90.0%–110.0%
3 SPECIFIC TESTS
pH 〈791〉: 3.9–4.9
4 ADDITIONAL REQUIREMENTS
Change to read:
Packaging and Storage: Package in tight, light-resistant containers. Store in a refrigerator (USP 1-May-2022) or at controlled room temperature.
Change to read:
Beyond-Use Date: NMT 90 days after the date on which it was compounded when stored in a refrigerator (USP 1-May-2022) or at controlled room temperature.
Labeling: Label it to indicate that it is to be well shaken before use, and to state the Beyond-Use Date.
USP Reference Standards 〈11〉
USP Prednisolone Sodium Phosphate RS

